News
In terms of quality of life, someone 75 years old, retired with significant memory problems, can still have friends and, “a ...
15m
DPA International on MSNEMA recommends approval of additional Alzheimer's treatment
The European Medicines Agency (EMA) cleared the way for the use of another drug to treat Alzheimer's disease on Friday.
UCSF researchers found the cancer drugs letrozole and irinotecan may reverse Alzheimer's effects, reducing tau protein clumps ...
A tiny flower-shaped particle could help to pave the way for a new treatment approach to Alzheimer's and Parkinson's that targets the root causes.
The spray treats inflammation in the brain and reduces it so that the patient's thinking and memory will no longer ...
As pharmaceutical companies struggle to develop Alzheimer’s treatments, scientists are searching for existing drugs that ...
Roche has obtained European approval for a blood test to help rule out Alzheimer’s disease, allowing patients to avoid ...
Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...
Individuals treated for breast cancer often develop cognitive issues, but they may have a lower risk for developing Alzheimer ...
Li, Huang, and Sirota chose 2 cancer drugs out of the top 5 drug candidates for laboratory testing. They predicted one drug, ...
9h
India Today on MSNUnderstanding frontotemporal dementia: The disease Bruce Willis is battling
Bruce Willis's diagnosis brings global attention to a misunderstood brain disorder that affects personality and speech before ...
21h
News Medical on MSNMathematics offers new clues in the fight against Alzheimer's
Mathematics may not be the first thing people associate with Alzheimer's disease research. But for Pedro Maia, an assistant ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results